Sugi Predict

Sugi Predict / Compounds / SCHEMBL19119784

SCHEMBL19119784

SCHEMBL19119784

CC1(C)OB(c2ccc(-c3ccc4ccccc4c3)c(-c3ccccc3)c2)OC1(C)C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 9/20 0.68
▸ LPL P06858 8/20 0.68
▸ PDGFRB P09619 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ DGAT1 O75907 1/20 0.39
▸ GSTP1 P09211 1/20 0.38
▸ SNCA P37840 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ P4HB P07237 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24377386 0.92 LIPG (0.67) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377155 0.91 LIPG (0.66) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377026 0.91 LIPG (0.66) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377025 0.90 LIPG (0.65) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL26280003 0.90 LIPG (0.55) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377090 0.90 LIPG (0.64) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL31642860 0.90 LIPG (0.61) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377083 0.89 LIPG (0.67) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL24377075 0.89 LIPG (0.62) LIPGLPLPDGFRBKDRDGAT1
SCHEMBL31643023 0.89 LIPG (0.60) LIPGLPLPDGFRBKDRDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10468606-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-11-05 — — US disclosed
US-20190019962-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-01-17 — — US disclosed
WO-2017119654-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC APPARATUS THEREFOR 덕산네오룩스 주식회사 2017-07-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019962-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, OR10J3 LIPG 1293/4885LPL 3161/4885PDGFRB 4885/4885
US-10468606-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof PIEZO1, OCIAD1, OR10J3 LIPG 1293/4885LPL 3161/4885PDGFRB 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.